Aldeyra Therapeutics (ALDX) stock slips as the company faces an FDA review delay for its lead drug reproxalap in dry eye ...

Elastic is experiencing robust GenAI adoption, particularly among large enterprise customers, supporting a reiterated buy ...

Analyst Andrew Percoco and his team expect the company to increase its fleet size to 1,000 vehicles on the road in 2026, up ...

I expect a special segment within energy to deliver substantial alpha in 2026 and beyond, surpassing traditional sector ...

Amphastar Pharmaceuticals faces flat growth and margin pressure as it shifts from generics to branded drugs. Learn why AMPH ...

Water utilities are undervalued by 18% vs. 11-year averages, while electricity/multi-utilities and gas utilities are slightly ...

Clearway Energy has a stable business model with predictable cash flows, underpinned by long-term PPAs. See why I rate CWEN ...

As artificial intelligence shakes up the economy and markets, the need for a massive buildout of data center infrastructure ...

PulteGroup is a Strong Buy, offering value amid housing shortages, robust growth, and strategic advantages. Click here to ...

Teck Resources and Anglo American received a key approval from the Canadian government for their merger that would create one ...

Touchstone Sands Capital International Growth Fund (Class A Shares, Load Waived) underperformed MSCI ACWI ex-U.S. Index for ...

NICE Ltd. trades at a steep discount despite solid profitability and sticky enterprise software revenue. Find out why the ...